Abstract: Apparatus and method support a neurological event screening for a medical device. The medical device assists a user in determining a configuration of the medical device for delivering an effective treatment for a nervous system disorder. The medical device detects a neurological event, such as a seizure, and reports a neurological event focus location and a neurological event spread to the user. The user may use the information to provide a configuration of a therapeutic delivery unit and associated therapy parameters. Therapeutic treatment is delivered to the patient, and the medical device is provided an indication of the patient's acceptance to the treatment. The user may modify the configuration and therapy parameters in order to achieve efficacy and acceptance. Depending upon the patient's acceptance, therapy is applied in either an open loop mode or a closed loop mode. The medical device determines whether the treatment is successful in accordance with a criterion.

Abstract: Apparatus and method support the configuration and testing of therapy parameters for a medical device system in the treatment of nervous system disorders. With the embodiment, the medical device system operates in a manual treatment therapy mode, in which the medical device system evaluates a set of information that is indicative of a system configuration. The medical device system determines if the set of information is acceptable. During the manual treatment therapy mode, the medical device system applies therapeutic treatment to a patient in accordance with the set of information. If the patient cannot tolerate the therapeutic treatment, the user indicates so through a user interface. The medical device system may associate the patient's intolerance to therapeutic treatments that equal or exceed the patient's level of tolerance. Moreover, the medical device system may use this information to prevent a delivery of therapeutic treatment that exceeds the patient's level of tolerance during a run mode.

Abstract: Apparatus and method support the synchronization and calibration of a plurality of clocks in a medical device system that may provide treatment to a patient with a nervous system disorder. The plurality of clocks, which may be located at different components of the medical device system, comprises a first clock and a second clock. The second clock may be synchronized to a first clock by disabling a run mode operation and setting the second clock to a selected time. When a reference time of the first clock approximately equals the selected time, the second clock enables the run mode operation. Additionally, a drift time that is indicative of a time difference between the first clock and the second clock is determined. If the drift time is greater than a predetermined amount, an indication to resynchronize the first and second clocks is provided.

Abstract: Apparatus and method support the synchronization and calibration of a plurality of clocks in a medical device system that may provide treatment to a patient with a nervous system disorder. The plurality of clocks, which may be located at different components of the medical device system, comprises a first clock and a second clock. The second clock may be synchronized to a first clock by disabling a run mode operation and setting the second clock to a selected time. When a reference time of the first clock approximately equals the selected time, the second clock enables the run mode operation. Additionally, a drift time that is indicative of a time difference between the first clock and the second clock is determined. If the drift time is greater than a predetermined amount, an indication to resynchronize the first and second clocks is provided.

Abstract: Apparatus and method support the synchronization and calibration of a plurality of clocks in a medical device system that may provide treatment to a patient with a nervous system disorder. The plurality of clocks, which may be located at different components of the medical device system, includes a first clock and a second clock. The second clock may be synchronized to a first clock by disabling a run mode operation and setting the second clock to a selected time. When a reference time of the first clock approximately equals the selected time, the second clock enables the run mode operation. Additionally, a drift time that is indicative of a time difference between the first clock and the second clock is determined. If the drift time is greater than a predetermined amount, an indication to resynchronize the first and second clocks is provided.

Abstract: Apparatus and method support a neurological event screening for a medical device. The medical device assists a user in determining a configuration of the medical device for delivering an effective treatment for a nervous system disorder. The medical device detects a neurological event, such as a seizure, and reports a neurological event focus location and a neurological event spread to the user. The user may use the information to provide a configuration of a therapeutic delivery unit and associated therapy parameters. Therapeutic treatment is delivered to the patient, and the medical device is provided an indication of the patient's acceptance to the treatment. The user may modify the configuration and therapy parameters in order to achieve efficacy and acceptance. Depending upon the patient's acceptance, therapy is applied in either an open loop mode or a closed loop mode. The medical device determines whether the treatment is successful in accordance with a criterion.

Abstract: Apparatus and method support the configuration and testing of therapy parameters for a medical device system in the treatment of nervous system disorders. With the embodiment, the medical device system operates in a manual treatment therapy mode, in which the medical device system evaluates a set of information that is indicative of a system configuration. The medical device system determines if the set of information is acceptable. During the manual treatment therapy mode, the medical device system applies therapeutic treatment to a patient in accordance with the set of information. If the patient cannot tolerate the therapeutic treatment, the user indicates so through a user interface. The medical device system may associate the patient's intolerance to therapeutic treatments that equal or exceed the patient's level of tolerance. Moreover, the medical device system may use this information to prevent a delivery of therapeutic treatment that exceeds the patient's level of tolerance during a run mode.

Abstract: Apparatus and method support the synchronization and calibration of a plurality of clocks in a medical device system that may provide treatment to a patient with a nervous system disorder. The plurality of clocks, which may be located at different components of the medical device system, comprises a first clock and a second clock. The second clock may be synchronized to a first clock by disabling a run mode operation and setting the second clock to a selected time. When a reference time of the first clock approximately equals the selected time, the second clock enables the run mode operation. Additionally, a drift time that is indicative of a time difference between the first clock and the second clock is determined. If the drift time is greater than a predetermined amount, an indication to resynchronize the first and second clocks is provided.

Abstract: A phosphor coating for gas discharge lamps is provided. The phosphor coating contains a nano-size phosphor which promotes adherence of the primary phosphor to the glass envelope. The phosphor coating is applied to the interior surface of the gas discharge lamp using an aqueous suspension containing the primary phosphor, the nano-size phosphor, and an organic binder.

Abstract: A neon gas discharge lamp is provided which produces an acceptable amber color emission for automotive applications. The red emission from the neon discharge when the lamp is operated in a pulsed mode is combined with a green emission from a substituted Y.sub.3 Al.sub.15 O.sub.12 :Ce phosphor coated on the interior surface of the lamp. The resulting amber emission meets both SAE and ECE amber color requirements. In particular, phosphor has the general formula:Y.sub.3-(a+b+c) Ce.sub.a M.sub.b V.sub.c Al.sub.5 O.sub.12where M is Gd or La;V are lattice vacanies;0.01.ltoreq.a.ltoreq.0.08;0.60.ltoreq.b.ltoreq.2.4; and0.ltoreq.c.ltoreq.0.1.

Abstract: A host acting as an optical emitter and a process of making the same for the .sup..about. 1.3 .mu.m to .sup..about. 1.55 .mu.m spectral region utilized in optical communications is disclosed. The host is Cr-activated willemite (Zn.sub.2 SiO.sub.4). Efficient band-emission at room temperature, with peak at 1.42 .mu.m, is observed on exiting the material in the near infrared, typically at 730 nm and 829 nm.

Abstract: A new and improved method of treating a manganese activated zinc silicate phosphor is described. The method comprises heating a manganese activated zinc silicate phosphor powder having cations consisting essentially of zinc, silicon, manganese, and tungsten and having a 350 nm reflectance less than 80% and a 275 nm reflectance greater than 13.5% to a temperature of about 1225.degree. C. in air. The phosphor powder is then cooled to room temperature and wet milled in an acid solution. The phosphor powder is then separated from the acid solution washed in water and dried to form a dry phosphor powder having a 350 nm reflectance equal to or greater than 80% and a 275 nm reflectance equal to or less than 13.5%.

Abstract: Apparatus for the manufacture of oriented chopped glass fiber mats from non-conductive fiber feed stock is disclosed. Apparatus includes means for increasing the conductance of the feed stock, electrically insulative transfer surface; means for establishing and maintaining a directional electric field to orient the chopped fibers, and a mat receiving surface to receive the oriented mat. The non-woven mat comprises a plurality of cut or chopped fibers having their longitudinal axes predominately disposed approximately parallel to a predetermined orientation axis lying in the plane of the mat. A preferred embodiment includes the incorporation of a glass fiber mat into a composite by applying a matrix resin to the mat in sufficient quantity to ensure the integrity of the composite. The process for manufacturing said non-woven oriented mats is also disclosed.

Abstract: The lumen maintenance of fluorescent lamps containing yttrium vanadate phosphors is markedly improved by the presence of a protective oxide layer for the phosphor. The protective oxide layer is produced by evaporating aluminum isopropoxide, in a vacuum, over phorphor particles forming a continuous aluminum isopropoxide over the phosphor particles. The isopropoxide coating is subsequently oxidized by lehring the phosphor at a temperature from about 500.degree. C. to 625.degree. C. forming an alumina coating on the phosphor particles.

Abstract: A method for producing manganese activated zinc silicate phosphor wherein the individual phosphor particles are surrounded with a non-particulate, conformal aluminum oxide coating is disclosed. The method comprises dry blending a mixture of components consisting essentially of zinc oxide, silicic acid, a source of manganese, ammonium chloride, ammonium fluoride, tungstic oxide, and silica, wherein the Zn+Mn/Si mole ratio is from about 1.95 to about 2.02, wherein the silica is colloidal and has a surface area of from about 50 to about 410 m.sup.2 per gram, and wherein the colloidal silica makes up from about 0.01% to about 1.0% by weight of the mixture; firing the resulting dry blend of components in a nitrogen atmosphere at a temperature of from about 1200.degree. C. to about 1300.degree. C.

Abstract: A fluorescent lamp containing a Y.sub.2 O.sub.3 or Al.sub.2 O.sub.3 coating on a layer of yttrium vanadate phosphor and a method of coating the layer of the yttrium vanadate phosphor with a continuous protective coating of Y.sub.2 O.sub.3 or Al.sub.2 O.sub.3 is described. The method comprises applying a coating of a metal, such as yttrium or aluminum, on the yttrium vanadate phosphor then lehring the metallic coating at about 500.degree. C. to about 625.degree. C. to form a continuous protective coating of Y.sub.2 O.sub.3 or Al.sub.2 O.sub.3 overlaying the layer of phosphor.

Abstract: A new and improved manganese activated zinc silicate phosphor is described. The phosphor has cations consisting essentially of zinc, silicon, manganese, and tungsten. The phosphor has an absolute reflectance less than or equal to 13.5% at 275 nm, an absolute reflectance equal to or greater than 80% at 350 nm, and a surface area from about 0.3 m.sup.2 /gm to about 0.4 m.sup.2 gm.

Abstract: A manganese activated zinc silicate phosphor and method for producing same is disclosed which comprises dry blending a mixture of components consisting essentially of zinc oxide, silicic acid, a source of manganese, ammonium chloride, ammonium fluoride, tungstic oxide and silica wherein the Zn+Mn/Si mole ratio is from about 1.95 to about 2.02, wherein the silica is colloidal and has a surface area of from about 50 to about 410 m.sup.2 /g, and wherein the colloidal silica makes up from about 0.01% to about 1.0% by weight, firing the blend in a nitrogen atmosphere at a temperature of from about 1200.degree. C. to about 1300.degree. C. for a sufficient time to produce the phosphor, and firing the phosphor in air at a temperature of from about 1175.degree. C. to about 1275.degree. C. for a sufficient time to diffuse the tungsten and manganese to the surfaces of the phosphor particles. Between the firing steps, the phosphor can be milled for from about 60 to 120 minutes to increase luminescence.

Abstract: A method for preventing the hydration/solubilization of the protective oxide coating of a phosphor is described. The method involves coating of the oxide coated phosphor particles with a continuous hydrophobic coating. After the phosphor particles are coated with the continuous hydrophobic coating and the continuous hydrophobic coating cured, they are added to a water-based suspension and subsequently processed into a lamp.

Abstract: A method for eliminating carbonaceous contaminants and preventing the hydration/solubilization of the oxide coating of a phosphor is described. The method involves the annealing of the oxide coated phosphor at a temperature and for a period sufficient to preclude adversely affecting the protective oxide coating on the phosphor during subsequent water-based suspension processing without detrimentally altering the phosphor. After annealing the phosphor is cooled and then added to a water-based suspension. The optimum conditions for annealing a manganese activated zinc silicate phosphor or a calcium halophosphate phosphor having a protective aluminum oxide coating are the combination of a temperature between about 700.degree. C. and about 850.degree. C. and for a period of time from about 15 minutes to about 20 hours.